Dashboard
Manage Tickers

ONCT


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
11/25/2024 21:05:40

gold-down-over-3-rigetti-computing-shares-spike-higher
Gold Down Over 3%; Rigetti Computing Share...
11/25/2024 19:18:59

crude-oil-down-3-chicago-fed-national-activity-index-falls-in-october
Crude Oil Down 3%; Chicago Fed National Ac...
11/25/2024 17:35:38

dow-surges-over-300-points-bath--body-works-posts-upbeat-earnings
Dow Surges Over 300 Points; Bath & Body Wo...
11/25/2024 14:47:44

on-november-22-oncternal-therapeutics-announced-that-nasdaq-plans-to-delist-its-stock-on-december-3-nasdaq-classified-the-company-as-public-shell--following-its-decision-to-lay-off-employees-and-explore-strategic-alternatives-filing
On November 22, Oncternal Therapeutics Ann...
11/25/2024 11:30:45

Nasdaq will file a delisting notice with the SEC. Oncternal has stated it will not appeal the decision. 

oncternal-therapeutics-announced-workforce-reduction-effective-december-2-2024-four-employees-will-remain-in-a-part-time-capacity-in-connection-with-exploration-of-strategic-alternatives-expects-24m-in-charges-from-workforce-reduction
Oncternal Therapeutics Announced Workforce...
11/14/2024 22:15:52

oncternal-therapeutics-has-been-granted-us-patent-number-12128026-titled-selective-androgen-receptor-degrader-ligands-and-methods-of-use-thereof-for-the-treatment-of-prostate-cancer
Oncternal Therapeutics Has Been Granted U....
10/29/2024 19:17:58

https://ppubs.uspto.gov/pubwebapp/external.html?q=(12128026).pn

oncternal-therapeutics-announces-updated-safety-and-efficacy-data-for-phase-12-study-of-onct-534-for-the-treatment-of-rr-metastatic-castration-resistant-prostate-cancer
Oncternal Therapeutics Announces Updated S...
10/22/2024 13:14:58

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) (the "Company") today announced updated data from its Phase 1/2 Study of ONC...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
10/15/2024 12:08:20

northland-capital-markets-downgrades-oncternal-therapeutics-to-market-perform-announces-2-price-target
Northland Capital Markets Downgrades Oncte...
09/12/2024 19:49:17

Northland Capital Markets analyst Carl Byrnes downgrades Oncternal Therapeutics (NASDAQ:ONCT) from Outperform to Market Perf...

dow-surges-over-100-points-modivcare-shares-plummet
Dow Surges Over 100 Points; ModivCare Shar...
09/12/2024 18:01:18

crude-oil-surges-3-kroger-posts-upbeat-earnings
Crude Oil Surges 3%; Kroger Posts Upbeat E...
09/12/2024 16:10:01

brookline-capital-downgrades-oncternal-therapeutics-to-hold
Brookline Capital Downgrades Oncternal The...
09/12/2024 15:16:58

Brookline Capital analyst Kemp Dolliver downgrades Oncternal Therapeutics (NASDAQ:ONCT) from Buy to Hold.

us-stocks-mixed-producer-prices-increase-in-august
US Stocks Mixed; Producer Prices Increase ...
09/12/2024 14:23:57

trading-halt-halt-status-updated-at-94000-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 9:40:...
09/12/2024 13:40:05

oncternal-therapeutics-to-discontinue-clinical-trials-for-onct-534-and-onct-808-due-to-lack-of-clinically-meaningful-results-and-high-capital-requirements-company-to-explore-strategic-alternatives-including-asset-sales-licensing-or-mergers-while-reducing-workforce-to-preserve-cash-resources
Oncternal Therapeutics To Discontinue Clin...
09/12/2024 13:01:48

trading-halt-halted-at-85500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 8:55:00 a.m. ET - ...
09/12/2024 12:55:04

hc-wainwright--co-maintains-buy-on-oncternal-therapeutics-lowers-price-target-to-18
HC Wainwright & Co. Maintains Buy on Oncte...
08/12/2024 09:52:15

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Oncternal Therapeutics (NASDAQ:ONCT) with a Buy and lowers the ...

oncternal-therapeutics-q2-2024-gaap-eps-289-beats-310-estimate-sales-801000k-beat-237500k-estimate
Oncternal Therapeutics Q2 2024 GAAP EPS $(...
08/08/2024 20:24:23

Oncternal Therapeutics (NASDAQ:ONCT) reported quarterly losses of $(2.89) per share which beat the analyst consensus estimate o...

hc-wainwright--co-reiterates-buy-on-oncternal-therapeutics-maintains-19-price-target
HC Wainwright & Co. Reiterates Buy on Onct...
07/16/2024 11:53:03

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Oncternal Therapeutics (NASDAQ:ONCT) with a Buy and maintains ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION